We develop innovative monoclonal antibodies
MediaPharma Srl is a drug discovery and development company focusing on Antibody-Drug Conjugates (ADCs) for the treatment of cancer and other severe diseases with unmet medical needs. At MediaPharma, scientists, doctors and entrepreneurs share the same values and have been working together for years
Advanced preclinical stage
We utilize leading-edge technologies for testing efficacy and safety of our products in preclinical models
Specific molecular targeting
Our ADCs are projected to target selectively cancer cells, while minimizing normal tissues
Interdisciplinary Collaboration
Our team liaises scientific, medical and entrepreneurial skills to hasten therapeutic innovation
Focus on severe diseases with unmeet medical needs
Our specialization aims at offering innovative solutions to improve patient’s quality of life
Multidisciplinary team with seasoned experience
Scientists, doctors and entrepreneurs collaborate to transform preclinical research in concrete therapy